SCHRODER INVESTMENT MANAGEMENT GROUP

Position in VERA — Vera Therapeutics, Inc.

CIK 1086619 London, X0

Position in VERA

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$19,486,647

+$17,877,359 QoQ

Shares Held

484,381

+1424.2% QoQ

Ownership

0.675%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SCHRODER INVESTMENT MANAGEMENT GROUP holds $603,082,920 across 77 Biotechnology names. VERA ranks #8 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	163,898	$73,187,011
2	TECH	BIO-TECHNE Corp	1,197,214	$62,566,403
3	EXEL	Exelixis, Inc.	525,533	$22,540,109
4	ALNY	Alnylam Pharmaceuticals, Inc.	66,662	$22,056,454
5	SLNO	Soleno Therapeutics Inc	648,827	$21,722,727
6	MDGL	Madrigal Pharmaceuticals, Inc.	39,852	$20,861,326
7	INSM	INSMED Inc	119,958	$19,615,531
8	VERA	Vera Therapeutics, Inc. This page	484,381	$19,486,647

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$19,486,647	484,381	+1424.2%	Shares	Sole	2026-05-14
2025-12-31	$1,609,288	31,779	-95.3%	Shares	Sole	2026-02-13
2025-09-30	$19,760,567	679,992	+82.4%	Shares	Sole	2025-11-13
2025-06-30	$8,781,966	372,749	-18.8%	Shares	Sole	2025-08-13
2025-03-31	$11,021,360	458,841	-5.4%	Shares	Sole	2025-05-13
2024-12-31	$20,516,782	485,145	+1.8%	Shares	Sole	2025-02-12
2024-09-30	$21,070,714	476,713	+10.1%	Shares	Sole	2024-11-13
2024-06-30	$15,672,162	433,172	+23.2%	Shares	Sole	2024-08-12
2024-03-31	$15,163,277	351,653	-68.3%	Shares	Sole	2024-05-14
2023-12-31	$17,086,564	1,110,960	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.